During the 40th Annual J.P. Morgan Healthcare Conference on Monday, Pfizer CEO Albert Bourla said that two doses of the Pfizer/BioNTech COVID-19 vaccine are “not enough” for protection against the new Omicron variant. “Omicron is a way more challenging target, so the two doses are not enough for Omicron,” Bourla said. “The third dose of the current vaccine is providing
Continue Reading
Today: July 31, 2026
